About Japan Early-stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS) The Japan Early-stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS) is an investigator-initiated study conducted as a multicenter, placebo-controlled, double-blind, randomized Phase III clinical trial to verify the efficacy and safety of high-dose methylcobalamin (mecobalamin) in patients with amyotrophic lateral sclerosis (ALS)
Your liver is responsible for processing vitamins and nutrients from the food you eat - turning them into formidable units that your body can use to produce key hormones, energy and recycle critical compounds, such as iron
The protein l-isoaspartyl (d-aspartyl) methyltransferase protects against dopamine-induced apoptosis in neuroblastoma SH-SY5Y cells
Diabetes, age, and duration of supplementation subgroup analysis for the effect of coenzyme Q10 on oxidative stress: A systematic review and meta-analysis
Many people take Glutathione IM injections to support healthy aging and long-term wellness
It is used to convert homocysteine to methionine, thus supporting cardiovascular and liver health